WebBuy-back Offer / Offer / Buy-back The Offer by Sun Pharmaceutical Industries Limited for 100% Buy-back of outstanding 154,517,050 6% Cumulative Redeemable Preference Shares of face value of Re.1/- each at a price of Rs. 1.03/- per Preference Share through T ender Offer. CDSL Central Depository Services (India) Limited DP Depository Participant WebMar 17, 2024 · New Delhi: Indian Drug giant Sun Pharmaceutical Industries has announced that its board has approved Rs 1,700 crore share buyback offer at a maximum price of Rs 425 per share. In a regulatory filing, Sun Pharma has announced that the Board of Directors of the Company, at its meeting held yesterday has, inter alia, approved the …
Sun Pharma completes Rs 675-crore share buyback
WebOct 21, 2016 · Sun Pharma has completed buyback of shares worth Rs 675 crore to return surplus funds to its shareholders. WebNov 26, 2013 · Reuters Market Eye - Sun Pharmaceutical Industries (NSI:SUNPHARMA) gains 1 percent after unit Taro Pharmaceutical Industries (TARO.N) announced the … integris medical supply store
The Industry’s Only Guaranteed Buy-Back Program-Terms and
WebSep 28, 2024 · Shares of Sun Pharmaceutical Industries moved higher by 5 per cent to Rs 512 on the BSE on Monday after the company announced closure of buyback of equity … In March 2024, Sun Pharma had launched a buyback offer to buy back 40 million … Unsubscribe to continue. This is a subscriber only feature Subscribe Now … 13 Banglore A1 First Floor, 25/3 Lavelle Road Bangaluru-560001 Karnataka … WebMar 17, 2024 · Mar 17, 2024, 14:45 IST. New Delhi, Mar 17 () Drug major Sun Pharmaceutical Industries on Tuesday said its board has approved Rs 1,700 crore … WebJun 23, 2016 · Sun Pharma is the world’s fifth largest specialty generic pharmaceutical company. The consolidated revenue for 12 months ending March 2016 is approximately $4.3 billion, of which US market ... integris mental health willow view